Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinoma
British journal of surgery2018Vol. 105(12), pp. 1639–1649
Citations Over TimeTop 10% of 2018 papers
Andrew Davies, Despoina Myoteri, Janine Zylstra, Cara Baker, Wahyu Wulaningsih, Mieke Van Hemelrijck, N. Maisey, William Allum, Elizabeth Smyth, James Gossage, Jesper Lagergren, David Cunningham, Mark Green, Mark Kelly, Sam Ngan, A. Qureshi, Andy Gaya, Nyree Griffin, Audrey Jacques, Vicky Goh, Harriet Deere, Fuju Chang, Ula Mahadeva, B. Gill‐Barman, Simi George, Jason Dunn, Sebastian Zeki, John Meenan, O. Hynes, G. Tham, C. Iezzi, Dionysios Dellaportas, Andrew Cowie, William Knight, Nicola Valeri
Abstract
Lymph node regression is a strong prognostic factor and may be more important than response in the primary tumour.
Related Papers
- → Lymph Node Recovery From Colorectal Resection Specimens Removed for Adenocarcinoma:Trends Over Time and a Recommendation for a Minimum Number of Lymph Nodes to be Recovered(1996)285 cited
- → Metastases in Small Lymph Nodes From Colon Cancer(1987)283 cited
- → Lymph sacs are not required for the initiation of lymph node formation(2008)63 cited
- → Lymph node density as a surrogate marker for positive lymph nodes(2010)3 cited
- → Supplementary Table S2 from Molecular Evolution Patterns in Metastatic Lymph Nodes Reflect the Differential Treatment Response of Advanced Primary Lung Cancer(2023)